Context Therapeutics
CNTX
CNTX
22 hedge funds and large institutions have $723K invested in Context Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
72% less capital invested
Capital invested by funds: $2.55M → $723K (-$1.82M)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$16.4K | |
| 2 | +$13.8K | |
| 3 | +$11.2K | |
| 4 |
Two Sigma Advisers
New York
|
+$9.11K |
| 5 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$4.67K |
Top Sellers
| 1 | -$745K | |
| 2 | -$584K | |
| 3 | -$186K | |
| 4 |
Renaissance Technologies
New York
|
-$49.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$37.9K |